(Q37941914)

English

Biomarkers of endothelial cell activation: candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals

scientific article published on 24 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

Biomarkers of endothelial cell activation: candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals (English)

1 reference

Europe PubMed Central

25 August 2017

0 references

0 references

author name string

Jun Zhang

1

1 reference

Europe PubMed Central

25 August 2017

Joseph P Hanig

2

1 reference

Europe PubMed Central

25 August 2017

Albert F De Felice

3

1 reference

Europe PubMed Central

25 August 2017

publication date

24 September 2011

1 reference

Europe PubMed Central

25 August 2017

Vascular Pharmacology

1 reference

Europe PubMed Central

25 August 2017

56

1 reference

Europe PubMed Central

25 August 2017

1-2

1 reference

Europe PubMed Central

25 August 2017

14-25

1 reference

Europe PubMed Central

25 August 2017

Endothelial cell heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating soluble adhesion molecules in ANCA-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Pathophysiological importance of antineutrophil antibodies in vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells. Biomarker of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): implications for the relevance as serological disease acti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

LAMPs and NETs in the pathogenesis of ANCA vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Vasculitis syndromes: LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Endothelial cell activation in patients with systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Von Willebrand factor in the outcome of temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Endothelial injury and repair in systemic vasculitis of the young

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Activation of endothelial cells in thrombosis and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Proteinase 3: A cofactor for the binding of antineutrophil cytoplasm antibodies (ANCA) to endothelial cells?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Drug-induced vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Investigation of the molecular mechanisms preceding PDE4 inhibitor-induced vasculopathy in rats: tissue inhibitor of metalloproteinase 1, a potential predictive biomarker

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Plasma endothelin-1 levels and circulating endothelial cells in patients with aortoarteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

The many faces of endothelial microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells in vascular disorders: new insights into an old concept

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Heterogeneity of expression of E- and P-selectins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Diagnostic role of endothelial microparticles in vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

S100A12 on circulating endothelial cells surface in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Soluble forms of P-, E- and L-selectin in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells and vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Mechanisms and markers of vascular damage in ANCA-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating Inflammatory Endothelial Cells Contribute to Endothelial Progenitor Cell Dysfunction in Patients with Vasculitis and Kidney Involvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Factor VIII related antigen (von Willebrand's factor) in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Pathogenesis of ANCA-associated vasculitis, an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Autoantibodies vex the vasculature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Drug-induced vascular injury--a quest for biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Netting neutrophils in autoimmune small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Serum interleukin-6 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Serum soluble E-selectin levels in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Clinical characteristics of patients with kawasaki disease and levels of peripheral endothelial progenitor cells and blood monocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Cytokines predict coronary aneurysm formation in Kawasaki disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Endothelial progenitor cells and arterial functions in the late convalescence period of Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating interleukin-1 beta in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Drug-induced vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Anti-neutrophil cytoplasm-associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Evaluation of plasma von Willebrand factor as a biomarker for acute arterial damage in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Serum levels of soluble adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Vascular-bed--specific hemostasis and hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Shining a LAMP on pauci-immune focal segmental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

ANCA-associated renal vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells: from bench to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Macrovascular and microvascular endothelium during long-term hypoxia: alterations in cell growth, monolayer permeability, and cell surface coagulant properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating activated endothelial cells in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating soluble selectins in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Cutaneous and systemic manifestations of drug-induced vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Influence of Plasma Exchange on Serum Levels of Cytokines and Adhesion Molecules in ANCA-Positive Renal Vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Biomarkers in peripheral blood associated with vascular injury in Sprague-Dawley rats treated with the phosphodiesterase IV inhibitors SCH 351591 or SCH 534385

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

SK&F 95654-induced acute cardiovascular toxicity in Sprague-Dawley rats--histopathologic, electron microscopic, and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Histopathology of vascular injury in Sprague-Dawley rats treated with phosphodiesterase IV inhibitor SCH 351591 or SCH 534385.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.09.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2011.09.002

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37941914&oldid=1734736045"